1. Fontolizumab, a humanised anti-interferon γ antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease. Issue 8 (28th February 2006) Authors: Hommes, D W; Mikhajlova, T L; Stoinov, S; Štimac, D; Vucelic, B; Lonovics, J; Zákuciová, M; D'Haens, G; Van Assche, G; Ba, S; Lee, S; Pearce, T Journal: Gut Issue: Volume 55:Issue 8(2006) Page Start: 1131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗